Cargando…
Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age
BACKGROUND: To evaluate the safety and efficacy of intra-arterial chemotherapy (IAC) for the primary or secondary treatment of infants diagnosed with advanced retinoblastoma before 3 months of age. METHODS: This single-center retrospective study included 39 infants (42 eyes) aged ≤3 months who were...
Autores principales: | Chen, Qiuying, Zhang, Bin, Dong, Yuhao, Mo, Xiaokai, Zhang, Lu, Xia, Jiejun, Zhang, Jing, Zhang, Shuixing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631809/ https://www.ncbi.nlm.nih.gov/pubmed/31307410 http://dx.doi.org/10.1186/s12885-019-5844-5 |
Ejemplares similares
-
Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis
por: Chen, Qiuying, et al.
Publicado: (2018) -
Efficacy of second-course intra-arterial chemotherapy in children for advanced retinoblastoma recurrence after intra-arterial chemotherapy
por: Jiang, Hua, et al.
Publicado: (2019) -
Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies
por: Chen, Miaojuan, et al.
Publicado: (2016) -
Sclero-conjunctival ischaemia secondary to intra-arterial chemotherapy for retinoblastoma
por: McAnena, Lisa, et al.
Publicado: (2020) -
Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma
por: Choi, Saerom, et al.
Publicado: (2013)